BIODRG

Metsera Embraces Pfizer’s $10 Billion Offer: An Inside Look at the Latest M&A Showdown

On November 7, 2023, Metsera, a company developing obesity drugs, accepted a $10 billion offer from Pfizer. This move seems ... Read more